Dr. Osama Al-Suleiman, MD
What this data tells you about Dr. Al-Suleiman
Dr. Osama Al-Suleiman is an interventional cardiology specialist in Clermont, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Al-Suleiman performed 5,729 Medicare services across 3,766 unique beneficiaries.
Between the years covered by Open Payments, Dr. Al-Suleiman received a total of $4,759 from 29 pharmaceutical and/or device companies across 233 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Al-Suleiman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 86774 | Clear | January 31, 2027 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,009 | $86 | $251 |
| Electrocardiogram (EKG), 12-lead | 939 | $10 | $29 |
| Regadenoson injection (Lexiscan) for heart stress test | 625 | $43 | $117 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 620 | $88 | $466 |
| Office visit, established patient (20-29 min) | 468 | $65 | $179 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 312 | $327 | $867 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 311 | $45 | $138 |
| Echocardiogram, transthoracic | 258 | $138 | $386 |
| Prothrombin time test (blood clotting) | 191 | $4 | $9 |
| New patient office visit (45-59 min) | 167 | $111 | $331 |
| Hospital follow-up visit, moderate complexity | 156 | $62 | $141 |
| Hospital follow-up visit, high complexity | 121 | $94 | $202 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 101 | $41 | $113 |
| Initial hospital admission, moderate complexity | 87 | $103 | $267 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 65 | $140 | $367 |
| Programming of dual lead pacemaker system | 51 | $57 | $160 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 45 | $18 | $53 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 45 | $25 | $69 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 27 | $805 | $2,186 |
| Remote pacemaker/defibrillator monitoring, 90 days | 16 | $14 | $45 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $80 | $213 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $14 | $36 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $2 | $7 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 15 | $18 | $48 |
| Cardiac catheterization | 15 | $230 | $609 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $10 | $26 |
| Ultrasound of both sides of head and neck blood flow | 12 | $141 | $374 |
| Ultrasound of leg arteries or artery grafts | 12 | $182 | $472 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Al-Suleiman is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 18% in FL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Al-Suleiman experienced with office visit, established patient (30-39 min)?
Does Dr. Al-Suleiman receive payments from pharmaceutical companies?
How do Dr. Al-Suleiman's costs compare to other interventional cardiologists in Clermont?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology